dihydroethidium has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Peng, Z; Qi, Y; Qiao, X; Su, X; Wang, L; Wang, Y | 1 |
| Du, J; Fan, YY; Fu, H; Fujisawa, Y; Hitomi, H; Hosomi, N; Kimura, S; Kiyomoto, H; Kohno, M; Lu, XM; Nagai, Y; Nakano, D; Nishiyama, A; Ohmori, K | 1 |
2 other study(ies) available for dihydroethidium and Kidney Diseases
| Article | Year |
|---|---|
Intermedin inhibits unilateral ureteral obstruction-induced oxidative stress via NADPH oxidase Nox4 and cAMP-dependent mechanisms.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenomedullin; Aldehydes; Animals; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Ethidium; Fibrosis; Gene Transfer Techniques; Isoquinolines; Kidney; Kidney Diseases; Lipid Peroxidation; Male; NADPH Oxidase 4; Neuropeptides; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Transforming Growth Factor beta1; Up-Regulation | 2017 |
Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats.
Topics: Aldosterone; Animals; Azetidinecarboxylic Acid; Blood Pressure; Body Weight; Calcium Channel Blockers; Collagen Type IV; Connective Tissue Growth Factor; Creatinine; Dihydropyridines; Ethidium; Gene Expression; Kidney; Kidney Diseases; Male; Mesangial Cells; NADPH Oxidases; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta | 2009 |